These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?
- Patterson Companies, Inc. PDCO stock rocketed 35.60% after the company announced it entered into a definitive agreement to be acquired by Patient Square Capital for approximately $4.1 billion.
- NewAmsterdam Pharma Company N.V. NAMS shares jumped 34.55% after the company announced topline data from its Phase 3 BROADWAY trial of Obicetrapib.
- Walgreens Boots Alliance, Inc. WBA gained 21.38% last week following a report from Sky News indicating that Sycamore Partners has approached various potential lenders to fund a possible acquisition of the company.
- NovoCure Limited NVCR stock rose 19.49%. Piper Sandler maintained an Overweight rating and raised the price target to $42.
- RH RH shares surged 18.60% after the company reported quarterly results and raised its guidance. Also, Baird maintained a Neutral rating on the stock and raised its price target from $300 to $400.
- Pactiv Evergreen Inc. PTVE stock upped 17.71% after the company announced it would merge with Novolex, in which Pactiv shareholders would receive $18.00 per share in cash.
- Comstock Resources, Inc. CRK shares escalated 15.70%.
- ReNew Energy Global plc RNW stock rose 15.47% after the company announced it received a $7.07 share buyout proposal from a consortium including Masdar, CPP Investments, ADIA and founder Sumant Sinha to acquire the remaining share capital.
- Alaska Air Group, Inc. ALK stock was up 15.15% after the company unveiled “Alaska Accelerate,” a strategy to boost profitability and issued a strong FY25 outlook. Analysts boosted the price target on the stock.
- Stevanato Group S.p.A. STVN stock upped 13.82%. Wolfe Research initiates coverage with an Outperform rating and a price forecast of $28.
Also Read:
- Tesla, Alphabet And Broadcom Are Among Top Large Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?
- Super Micro Computer, Adobe And Nucor Are Among Top Large Cap Losers Last Week (December 9-13): Are The Others In Your Portfolio?
Image via Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in